
Unlocking General Catalyst's Customer Value Fund: The Top US Subscription Companies Poised for Non-Dilutive Growth
Tiger Tracks · Eye of the Tiger · PE/VC · April 2026
Tiger Tracks · Eye of the Tiger · Data · October 2026
By May 2025, General Catalyst's Customer Value Fund had provided capital to nearly 50 companies, structured so that each company repays the capital plus a fixed, capped percentage of the revenue generated by that spend [2]. As outlined in General Catalyst's "Unbundling of Growth Equity" framework, funding customer acquisition costs (CAC) with dilutive equity is an inefficient allocation of capital when that spend is predictable and measurable [1]. The CVF represents a structural shift, offering non-dilutive capital designed specifically to fund high-ROI marketing and sales engines.
This intelligence briefing identifies and analyzes private US subscription and repeat-purchase companies that align with the CVF mandate. To qualify, companies must be headquartered in the United States, operate on a subscription or high-repeat-purchase model, remain privately held, and show a minimum estimated monthly paid media spend of $2 million. The analysis excludes existing General Catalyst portfolio companies, including CVF recipients, to focus on net-new whitespace. Ad spend, LTV:CAC and composite scores are Tiger Tracks model estimates and are labeled as such throughout.
1. The Customer Value Fund Thesis
Not all capital needs are created equal. Growth-stage companies have historically used equity to fund both foundational investments (research and development, infrastructure, core team expansion) and variable, highly measurable investments (digital marketing, sales commissions). General Catalyst's view is that using expensive, dilutive equity to fund predictable customer acquisition engines erodes founder and early-investor value [1].
Under the model, General Catalyst pre-funds a company's sales and marketing budget, is entitled only to the customer value created by that spend, and caps that entitlement at a fixed amount; if the spend does not perform, General Catalyst owns the downside and is paid only when the company is paid [1]. The Prenetics IM8 agreement shows how the terms work in practice: General Catalyst can finance up to 70% of monthly marketing spend, returns are tracked by monthly customer cohort, no equity or warrants are issued, and once a cohort has repaid the investment plus its capped return, all later value from those customers stays with the company [4]. The CVF also has its own limited partners, separate from General Catalyst's main funds [6].
| Company | CVF commitment | Announced | Source |
|---|---|---|---|
| Grammarly | $1 billion | May 2025 | Grammarly [3] |
| Musely | More than $360 million | May 2026 | TechCrunch [6] |
| Prenetics (IM8) | $1 billion | July 2026 | Prenetics [4] |
| Function Health | $450 million | July 2026 | Function [7] |
| Motive | More than $1.3 billion | September 2026 | Motive [5] |
When a company has a proven LTV:CAC ratio, predictable churn and scalable marketing channels, customer acquisition becomes closer to a mathematical equation than a venture risk. Our framework holds that the ideal CVF candidate shows four characteristics: a predictable revenue model, strong unit economics (estimated LTV:CAC ideally above 4.0x and trending upward), an acquisition engine capable of deploying millions monthly into paid media, and a clear path to profitability, signaling that capital is needed for acceleration rather than survival.
2. Methodology and Scoring Framework
The roster began as a dataset of private US companies scored with a Tiger Tracks composite model in April 2026, then was re-verified company by company in October 2026.
Data Collection and Filtering
The initial dataset was compiled from private market intelligence platforms, ad spend monitoring tools and financial disclosures. Screening required companies to be privately held, headquartered in the United States and above an estimated $2 million in monthly paid media spend, with General Catalyst portfolio companies, public companies, non-US entities and duplicates removed. The April 2026 dataset contained 77 companies. The October 2026 pass checked each company's ownership status, General Catalyst affiliation and named investors against company announcements, investor releases and trade press, and removed every company that failed a criterion or could not be verified.
Composite Scoring Model (100-Point Scale)
The companies were scored on a 100-point composite model designed to mirror CVF investment priorities. All inputs are Tiger Tracks estimates from April 2026 and were not re-scored in October 2026.
- LTV:CAC Ratio (25 points): The core measure of unit economic efficiency. Estimated ratios above 10.0x received maximum points.
- Ad Spend Momentum (20 points): Trajectory of marketing investment. Accelerating spend indicates a working acquisition engine.
- EBITDA Trajectory (20 points): Estimated profitability status plus an improving trajectory.
- Enterprise Value Trend (15 points): Estimated market momentum and valuation trajectory.
- Ad Spend Scale (10 points): Rewards larger acquisition engines. Estimated monthly spend above $12M received maximum points.
- LTV:CAC Trend (10 points): Rewards improving efficiency over time.
3. The Verified Landscape
Thirty-five of the original 77 companies were removed in October 2026, leaving 42. Five of the removals trace to General Catalyst itself: those companies had taken General Catalyst capital or been absorbed by a CVF company, which put them outside the whitespace this analysis targets.
| Removal reason | Companies removed |
|---|---|
| Now a General Catalyst or CVF company | Function Health ($450M CVF financing, July 2026) [7]; Deel (General Catalyst bought into a $300M secondary sale, February 2025) [8]; Aura (General Catalyst named as an investor) [9]; Gusto (General Catalyst investor since its 2014 round as ZenPayroll) [10]; Superhuman (acquisition by Grammarly, a CVF company, announced July 2025) [11] |
| Now public or acquired by a public company | Hinge Health (NYSE IPO, May 2025) [12]; Figma (NYSE IPO, July 2025) [13]; Brex (acquired by Capital One, April 2026) [14] |
| Not an independent private company (listed, a subsidiary, acquired or under a pending sale) | Klaviyo, Grove Collaborative, Bark, Nuvation Bio, Factor (HelloFresh), Nuuly (URBN), Lively (Wacoal), Thinx (Kimberly-Clark), Parade, Stash, Daily Harvest, Ollie, Keeps, Sunbasket, Winc, Headspace |
| Headquartered outside the US | Oura Health, Babbel |
| Status or investors could not be verified | Trade Coffee, Maximus, Brilliant, Gainful, Thistle, Firstleaf, Yotpo, Calibrate, Kidpik |
The Top CVF Investment Targets
1. Hungryroot (Model Score: 98)
An AI-powered grocery and meal subscription service. With an estimated LTV:CAC ratio of 12.6x and an estimated $8M in monthly spend, Hungryroot combines scale and efficiency in a notoriously difficult grocery delivery vertical, and its AI-driven personalization is central to its retention.
2. Rippling (Model Score: 96)
An HR and payroll SaaS platform with an estimated 12.0x LTV:CAC ratio. The B2B SaaS model provides exceptional revenue predictability, and the multi-product platform creates deep switching costs that sustain high LTV.
3. Attentive (Model Score: 94)
An SMS and email marketing SaaS platform with an estimated 10.0x LTV:CAC ratio. As brands shift spend to retention and lifecycle marketing, Attentive's underlying market tailwinds are strong.
4. Notion (Model Score: 94)
The productivity SaaS platform shows an estimated 10.0x LTV:CAC ratio. Its product-led growth motion is increasingly supplemented by paid acquisition, which lowers blended CAC.
5. WHOOP (Model Score: 93)
A fitness wearable company built on a membership model, with an estimated 9.0x LTV:CAC ratio and accelerating estimated spend.
6. Misfits Market (Model Score: 91)
Online grocery delivery with a sustainability angle and an estimated 8.0x LTV:CAC ratio, a strong profile for a typically difficult vertical.
7. Thorne (Model Score: 91)
A premium supplement company with an estimated 9.0x LTV:CAC ratio. Its science-backed positioning supports premium pricing and repeat subscription. Thorne has been privately held by L Catterton since a 2023 take-private [15].
Six companies follow at a model score of 89: Hone Health, Prose, Ritual, Kin Insurance, Olipop and Lovevery.
Full Ranked Prospect List
Ad spend, LTV:CAC and scores are Tiger Tracks model estimates from April 2026. Investor names were verified in October 2026 against company and investor announcements and trade press, and are not exhaustive. Estimated enterprise values and EBITDA trends from the original list were removed because they could not be sourced.
| Rank | Company | Vertical | Monthly Ad Spend (TT est.) | LTV:CAC (TT est.) | Model Score | Key Investors (verified) |
|---|---|---|---|---|---|---|
| 1 | Hungryroot | Food/Meal Delivery | $8.0M | 12.6x | 98 | L Catterton, Lightspeed Venture Partners, Crosslink Capital, Lerer Hippeau |
| 2 | Rippling | SaaS/HR | $6.0M | 12.0x | 96 | Y Combinator, Sands Capital, GIC, Goldman Sachs Growth, Baillie Gifford |
| 3 | Attentive | SaaS/Marketing | $3.5M | 10.0x | 94 | Bain Capital Ventures, Sequoia Capital, IVP, Coatue Management |
| 4 | Notion | SaaS/Productivity | $4.0M | 10.0x | 94 | Sequoia Capital, Coatue Management |
| 5 | WHOOP | Fitness/Wearable | $8.0M | 9.0x | 93 | Collaborative Fund, IVP, Mubadala, Qatar Investment Authority |
| 6 | Misfits Market | Food/Grocery | $5.5M | 8.0x | 91 | SoftBank Vision Fund 2, Accel |
| 7 | Thorne | Health/Supplements | $5.0M | 9.0x | 91 | L Catterton (take-private, 2023) |
| 8 | Hone Health | Health/Telehealth | $4.5M | 8.1x | 89 | Tribe Capital, Republic Capital, Vibe VC |
| 9 | Prose | Beauty/Personal Care | $3.0M | 9.0x | 89 | Insight Partners, Forerunner Ventures, Lerer Hippeau |
| 10 | Ritual | Health/Supplements | $3.5M | 8.0x | 89 | Norwest Venture Partners, Forerunner Ventures, Founders Fund |
| 11 | Kin Insurance | Fintech/Insurance | $4.0M | 8.0x | 89 | QED Investors, Commerce Ventures, Flourish Ventures, Hudson Structured Capital Management |
| 12 | Olipop | Food/Beverage | $4.0M | 8.0x | 89 | J.P. Morgan Growth Equity Partners |
| 13 | Lovevery | Children's Education | $3.5M | 8.0x | 89 | The Chernin Group, Maveron, Reach Capital, Collaborative Fund |
| 14 | Nerdio | SaaS/IT Management | $2.0M | 9.0x | 87 | General Atlantic, Lead Edge Capital, StepStone |
| 15 | Postscript | SaaS/SMS Marketing | $2.0M | 9.0x | 87 | 01 Advisors, Greylock, Accomplice, Twilio Ventures |
| 16 | Spring Health | Mental Health/B2B | $2.0M | 9.0x | 87 | Generation Investment Management |
| 17 | Gorgias | SaaS/Customer Support | $2.5M | 9.6x | 87 | Transpose Platform, Shopify, CRV, Alven |
| 18 | Seed Health | Health/Supplements | $2.5M | 9.0x | 87 | The Craftory, Founders Fund, 8VC |
| 19 | Spot & Tango | Pet Care | $2.0M | 8.0x | 87 | Valor Equity Partners |
| 20 | Dollar Shave Club | Beauty/Men's Grooming | $3.5M | 6.0x | 84 | Nexus Capital Management (majority, 2023), Unilever (minority) |
| 21 | The Farmer's Dog | Pet Care | $5.0M | 9.6x | 83 | Insight Partners, Shasta Ventures, Forerunner Ventures |
| 22 | Webflow | SaaS/Web Development | $3.5M | 10.0x | 76 | Y Combinator (Continuity), Accel, CapitalG |
| 23 | Brightline | Mental Health/Pediatric | $2.8M | 8.0x | 75 | KKR, GV, Oak HC/FT, Threshold Ventures |
| 24 | Found | Health/Weight Loss | $3.8M | 6.8x | 72 | IVP, WestCap, The Chernin Group |
| 25 | Manscaped | Beauty/Men's Grooming | $5.5M | 6.0x | 72 | Kaktus Capital, Rx3 Venture Partners, Scala Ventures |
| 26 | Function of Beauty | Beauty/Personal Care | $3.5M | 8.0x | 71 | L Catterton |
| 27 | Recharge | SaaS/Subscription Commerce | $2.0M | 10.0x | 70 | Summit Partners, ICONIQ Growth, Bain Capital Ventures |
| 28 | Lyra Health | Mental Health/B2B | $2.5M | 8.0x | 69 | Dragoneer, Salesforce Ventures, Coatue Management |
| 29 | Lattice | SaaS/HR | $2.5M | 9.6x | 69 | Thrive Capital, Tiger Global, Dragoneer, Founders Fund, Khosla Ventures |
| 30 | AG1 (Athletic Greens) | Health/Supplements | $12M | 7.8x | 68 | Alpha Wave Ventures, Bolt Ventures |
| 31 | Curology | Beauty/Skincare | $4.0M | 7.2x | 66 | Advance Venture Partners, Sherpa Capital, Forerunner Ventures |
| 32 | Skillshare | EdTech | $4.0M | 6.0x | 66 | OMERS Growth Equity, Union Square Ventures |
| 33 | Current | Fintech/Neobank | $3.0M | 7.5x | 66 | Andreessen Horowitz, Tiger Global |
| 34 | Ipsy | Beauty/Subscription Box | $5.0M | 6.0x | 64 | TPG Growth, Sherpa Capital |
| 35 | Harry's (Mammoth Brands) | Beauty/Men's Grooming | $6.0M | 6.0x | 64 | Alliance Consumer Growth, Temasek, Tao Capital Partners |
| 36 | FabFitFun | Beauty/Lifestyle Box | $4.0M | 6.0x | 62 | Kleiner Perkins, NEA, Upfront Ventures |
| 37 | KiwiCo | Children's Education | $4.5M | 6.0x | 62 | First Round Capital, Forerunner Ventures, Comcast Ventures (largely self-funded since 2015) |
| 38 | EarnIn | Fintech/Earned Wage Access | $3.5M | 6.0x | 62 | Andreessen Horowitz, Matrix Partners, Ribbit Capital, Spark Capital, Coatue Management |
| 39 | Carta | SaaS/Cap Table | $2.5M | 10.0x | 56 | Andreessen Horowitz, Union Square Ventures, Meritech Capital, Tribe Capital, Silver Lake Waterman |
| 40 | Cerebral | Mental Health | $5.5M | 2.5x | 28 | SoftBank Vision Fund 2, WestCap, Access Industries |
| 41 | Noom | Health/Weight Loss | $14M | 2.6x | 24 | Silver Lake, Oak HC/FT |
| 42 | Calm | Mental Health/Wellness | $6.0M | 3.0x | 20 | Lightspeed Venture Partners, TPG, Insight Partners |
4. Unit Economics vs. Acquisition Scale
The relationship between estimated unit economics (LTV:CAC) and estimated acquisition scale (monthly ad spend) defines each company's strategic posture. Four archetypes emerge from the model.
- Prime Targets: Companies such as Hungryroot, Rippling and WHOOP combine estimated LTV:CAC above 7x with estimated spend above $5M a month. These are the most direct fits for the CVF, capable of deploying large tranches of capital efficiently.
- Efficiency Leaders: Companies with high estimated LTV:CAC but lower absolute spend, such as Postscript and Recharge. CVF capital could unlock scale if the market permits.
- Scale Players: Companies spending heavily (above $5M a month, estimated) with LTV:CAC below 7x, such as Manscaped and Harry's. These businesses prioritize market share over immediate efficiency.
- Watch List: Companies with lower estimated efficiency, such as Cerebral, Noom and Calm, which would need model improvements before qualifying for large-scale non-dilutive capital.
Profitability was a scoring input, but company-level EBITDA status could not be independently verified for most private companies, so this briefing does not report it.
5. Vertical Market Analysis
High-performing subscription companies cluster in verticals that lend themselves to predictable revenue and high retention.
B2B SaaS: The Efficiency Engine
B2B SaaS leads the upper tier of the scoring model. Companies in this vertical benefit from high contract values, deep product integration that lowers churn, and measurable digital acquisition channels, and several SaaS companies in the roster carry model LTV:CAC estimates at or near 10.0x. This vertical is the lowest-risk deployment of CVF capital because enterprise retention is predictable.
Health and Wellness: High Value, High Retention
Telehealth and specialized supplements represent a large deployment of paid media. Companies like Hone Health and Thorne show that consumers maintain long-term subscriptions for personalized health solutions. Unit economics depend on the condition being addressed; chronic or ongoing needs yield higher LTVs than acute or short-term treatments. The category is already attracting CVF capital: Function Health's $450 million financing in July 2026 is the clearest example [7].
Food and Beverage: The Scale Challenge
Food and beverage subscription accounts for a large portion of total ad spend but faces tougher unit economics than SaaS or health. High operational costs, complex logistics and consumer fatigue tend to depress LTV:CAC ratios. Hungryroot is the exception in the model, using AI and personalization to support retention and efficiency.
6. Investor Syndicate Intelligence
The investors behind the 42 qualifying companies indicate where co-investment relationships could generate CVF deal flow. Forerunner Ventures and Coatue Management appear most often in the verified investor lists, and investors appearing across several companies represent the highest-priority relationship targets. Counts below reflect only the investors named in the verified table above and understate full syndicates.
| Investor | Portfolio Count | Qualifying Companies |
|---|---|---|
| Forerunner Ventures | 5 | Prose, Ritual, The Farmer's Dog, Curology, KiwiCo |
| Coatue Management | 4 | Attentive, Notion, Lyra Health, EarnIn |
| Andreessen Horowitz | 3 | Current, EarnIn, Carta |
| Founders Fund | 3 | Ritual, Seed Health, Lattice |
| Insight Partners | 3 | Prose, The Farmer's Dog, Calm |
| IVP | 3 | Attentive, WHOOP, Found |
| L Catterton | 3 | Hungryroot, Thorne, Function of Beauty |
| Accel | 2 | Misfits Market, Webflow |
| Bain Capital Ventures | 2 | Attentive, Recharge |
| Collaborative Fund | 2 | WHOOP, Lovevery |
| Dragoneer | 2 | Lyra Health, Lattice |
| Lerer Hippeau | 2 | Hungryroot, Prose |
| Lightspeed Venture Partners | 2 | Hungryroot, Calm |
| Oak HC/FT | 2 | Brightline, Noom |
| Sequoia Capital | 2 | Attentive, Notion |
| Sherpa Capital | 2 | Curology, Ipsy |
| SoftBank Vision Fund 2 | 2 | Misfits Market, Cerebral |
| The Chernin Group | 2 | Lovevery, Found |
| Tiger Global | 2 | Lattice, Current |
| TPG (incl. TPG Growth) | 2 | Ipsy, Calm |
| Tribe Capital | 2 | Hone Health, Carta |
| Union Square Ventures | 2 | Skillshare, Carta |
| WestCap | 2 | Found, Cerebral |
| Y Combinator | 2 | Rippling, Webflow |
7. Whitespace Opportunities
The highest-signal targets are high-scoring companies that are not backed by large growth equity, private equity, crossover or sovereign investors. They show strong modeled unit economics without the cap table complexity of heavily syndicated late-stage rounds.
Priority Whitespace Target List
Companies with model scores of 82 or higher whose verified investors are venture firms only, with no large growth equity, private equity, crossover or sovereign investor named. Estimates are Tiger Tracks model outputs.
| Company | Vertical | LTV:CAC (TT est.) | Monthly Spend (TT est.) | Model Score | Known Investors |
|---|---|---|---|---|---|
| Hone Health | Health/Telehealth | 8.1x | $4.5M | 89 | Tribe Capital, Republic Capital, Vibe VC |
| Postscript | SaaS/SMS Marketing | 9.0x | $2.0M | 87 | 01 Advisors, Greylock, Accomplice, Twilio Ventures |
| Seed Health | Health/Supplements | 9.0x | $2.5M | 87 | The Craftory, Founders Fund, 8VC |
8. Priority Target List
Based on the composite model, the following companies are the highest-priority targets for CVF engagement, each with a brief investment thesis.
Hungryroot
Operates at the intersection of scale ($8M a month, estimated) and efficiency (12.6x LTV:CAC, estimated). AI-driven personalization creates a defensible position in grocery delivery.
Rippling
Estimated 12.0x LTV:CAC with significant scale. Predictable enterprise revenue makes it a strong candidate for large-scale non-dilutive facilities, and the multi-product platform creates switching costs that sustain LTV.
Attentive
Estimated 10.0x LTV:CAC in SMS and email marketing. As brands shift spend to retention and lifecycle marketing, Attentive's underlying market tailwinds are strong.
WHOOP
A membership-based fitness wearable with estimated 9.0x LTV:CAC and accelerating estimated spend. Recurring membership revenue and hardware integration create switching costs.
Thorne
Premium supplements with estimated 9.0x LTV:CAC. Science-backed positioning commands premium pricing and drives high LTV through repeat subscription.
Misfits Market
Grocery delivery with a sustainability angle and estimated 8.0x LTV:CAC, a strong profile in a typically difficult vertical driven by a differentiated value proposition.
Hone Health
The highest-scoring whitespace company, with estimated 8.1x LTV:CAC and an estimated $4.5M in monthly spend, backed only by venture investors.
9. Strategic Outlook and Future Scenarios
The role of non-dilutive capital in the growth-stage stack is expanding quickly. Three futures are plausible over the next 24 to 36 months.
The first scenario is the most likely because the market is already moving there: the CVF had funded nearly 50 companies by May 2025 [2], and single commitments of $1 billion or more followed for Grammarly, IM8 and Motive between May 2025 and September 2026 [3][4][5]. The wild card is accounting and investor scrutiny. IM8 records its CVF facility as a financial liability, with the return component booked as interest expense [4], so a cohort that underperforms shows up directly in reported results, and a visible miss could slow adoption. The strategic implication is that measurement becomes collateral: companies that can prove cohort-level payback will get capital on the best terms.
Conclusion
The Customer Value Fund is an important evolution in growth-stage financing. By isolating and funding the predictable engine of customer acquisition, it gives founders an alternative to dilution while pricing risk at the cohort level. The verification pass also carries a lesson: nearly half of a six-month-old roster had to be removed, and five of those companies had already taken General Catalyst capital or joined a CVF company. The 42 companies that remain have the scale and modeled unit economics to deploy non-dilutive capital effectively, but the deciding factor will be proof. Data and AI can surface the targets and model the cohorts; people still have to judge which acquisition engines are durable and earn the trust to fund them. That is the Human-Led, AI-Augmented approach this market rewards.
References
- General Catalyst, Singhvi, P., and Mohan, K. (n.d.). The Unbundling of "Growth" Equity. https://www.generalcatalyst.com/stories/the-unbundling-of-growth-equity
- TechCrunch, Temkin, M. (May 29, 2025). Grammarly secures $1B in non-dilutive funding from General Catalyst. https://techcrunch.com/2025/05/29/grammarly-secures-1b-in-non-dilutive-funding-from-general-catalyst/
- Grammarly. (May 29, 2025). Grammarly Announces $1 Billion Growth Financing With General Catalyst. https://www.grammarly.com/blog/company/grammarly-announces-growth-financing/
- Prenetics Global Limited. (July 14, 2026). Prenetics' IM8 Secures $1 Billion Growth Financing from General Catalyst's Customer Value Fund (CVF). https://www.globenewswire.com/news-release/2026/07/14/3327198/0/en/prenetics-im8-secures-1-billion-growth-financing-from-general-catalyst-s-customer-value-fund-cvf.html
- Motive. (September 10, 2026). Motive Secures $1.3 Billion from General Catalyst to Fund Expansion. https://gomotive.com/blog/motive-financing-general-catalyst/
- TechCrunch, Temkin, M. (May 1, 2026). Musely secures $360M from General Catalyst without giving up equity. https://techcrunch.com/2026/05/01/musely-secures-360m-from-general-catalyst-without-giving-up-equity/
- Function. (July 30, 2026). Function Secures $450 Million Growth Financing from General Catalyst's Customer Value Fund (CVF). https://www.prnewswire.com/news-releases/function-secures-450-million-growth-financing-from-general-catalysts-customer-value-fund-cvf-302838766.html
- TechCrunch, Azevedo, M. A. (February 4, 2025). Deel unloads $300M in secondary sale, brings General Catalyst on as an investor. https://techcrunch.com/2025/02/04/deel-unloads-300m-in-secondary-sale-brings-general-catalyst-on-as-an-investor/
- SecurityWeek. (October 21, 2021). Consumer Security Firm Aura Raises $200 Million at $2.5 Billion Valuation. https://www.securityweek.com/consumer-security-firm-aura-raises-200-million-25-billion-valuation/
- TechCrunch. (February 19, 2014). Cloud-Based Payroll App ZenPayroll Raises $20M From General Catalyst And Kleiner At A $100M-Plus Valuation. https://techcrunch.com/2014/02/19/cloud-based-payroll-app-zenpayroll-raises-20m-from-general-catalyst-and-kleiner-at-a-100m-plus-valuation
- SiliconANGLE, Deutscher, M. (July 1, 2025). Grammarly acquires email client developer Superhuman. https://siliconangle.com/2025/07/01/grammarly-acquires-email-client-developer-superhuman/
- Hinge Health. (May 21, 2025). Hinge Health Announces Pricing of Initial Public Offering. https://ir.hingehealth.com/news/news-details/2025/Hinge-Health-Announces-Pricing-of-Initial-Public-Offering/default.aspx
- Figma. (July 30, 2025). Figma Announces Pricing of Initial Public Offering. https://www.figma.com/blog/ipo-pricing/
- Capital One. (April 7, 2026). Capital One Completes Acquisition of Brex. https://www.capitalone.com/about/newsroom/capital-one-completes-acquisition-of-brex/
- Thorne HealthTech. (October 16, 2023). L Catterton Completes Acquisition of Thorne HealthTech, Inc. https://www.thorne.com/press-releases/l-catterton-completes-acquisition-of-thorne-healthtech-inc
Published by Tiger Tracks. Eye of the Tiger Intelligence Series.
Eye of the Tiger
Get our research in your inbox
Strategic research and tactical playbooks for operators and investors. No spam, unsubscribe anytime.
Tiger Tracks • tigertracks.ai
